Evaluation of low dose famciclovir as herpes simplex virus and varicella zoster virus prophylaxis in cytomegalovirus low-risk solid organ transplant recipients.

Ashley Crouch Mariesa Le Christin Rogers Sarah Shao Camille Nelson Kotton

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2021)

Nationwide, the most common antiviral prophylaxis used in CMV low-risk SOT recipients is acyclovir 400 mg twice daily. Among patients receiving once daily famciclovir for CMV low-risk antiviral prophylaxis, there was no HSV/VZV/CMV infection while on prophylaxis. Once daily famciclovir may provide an effective and convenient once daily dosing regimen for antiviral prophylaxis in CMV low-risk SOT recipients.

Keyphrases

herpes simplex virus
low dose
physical activity
high dose
epstein barr virus
diffuse large b cell lymphoma